At a glance
- Originator Colgate-Palmolive
- Developer Colgate-Palmolive; MacroChem
- Class Antineoplastics; Osteoporosis therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hypercalcaemia; Osteitis deformans; Postmenopausal osteoporosis
Most Recent Events
- 01 Sep 2005 Discontinued - Preclinical for Hypercalcaemia in USA (unspecified route)
- 01 Sep 2005 Discontinued - Preclinical for Osteitis deformans in USA (unspecified route)
- 01 Sep 2005 Discontinued - Preclinical for Postmenopausal osteoporosis in USA (unspecified route)